Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
gptkb:stock_market_index |
| gptkbp:CEO |
gptkb:Chad_Robins
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
diagnostics
immune-driven medicine sequencing technologies |
| gptkbp:foundedYear |
2009
|
| gptkbp:hasCompany |
Adaptive Biotechnologies Corporation
|
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASDAQ:ADPT
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:IPODate |
2019-06-27
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ADPT
|
| gptkbp:website |
https://www.adaptivebiotech.com/
|
| gptkbp:bfsParent |
gptkb:Adaptive_Biotechnologies
|
| gptkbp:bfsLayer |
7
|